Technology and Innovation and Public Health | Johns Hopkins

Biostatistician Elizabeth Stuart (in purple) makes a point to HHS assistant secretary Micky Tripathi; other AI event panelists (l to r): Alison Snyder, John Auerbach, and Jesse Ehrenfeld.

AI in Public Health: Gaps, Disparities, and Remarkable Potential

October 09, 2024

Public health experts extolled the promise of AI to solve longstanding public health problems in an October 8 panel discussion but also raised concerns about its potential for exacerbating inequity.

Health Policy

Medicine

Technology and Innovation

Global Health NOW

Researchers Validate and Improve the Ability of Mobile Health Applications to Predict Mortality in the U.S. Population

June 27, 2022

Findings show that an improved C-Score can identify 87% of individuals living in the U.S. who will experience premature death.

Noncommunicable Diseases

Technology and Innovation

Department of International Health

What You Need to Know About the Novavax Protein-Based Vaccine

June 10, 2022

The FDA has authorized Novavax, a protein-based vaccine, for emergency use. Here’s what you need to know.

COVID-19

Technology and Innovation

Vaccines

Bloomberg School

Study of Privately Insured Patients Finds Short-Term Telehealth Follow-Up Comparable to Most In-Person Care During First Year of COVID-19 Pandemic

April 27, 2022

More patients with upper respiratory symptoms who started with telehealth consults required follows-ups, likely for COVID-19 assessment.

Health Policy

Technology and Innovation

Bloomberg School

A health worker provides medical advice on HIV/AIDS testing in Lagos, Nigeria, May 1, 2021. Image: Emmanuel Osodi/Majority World/Universal Images Group via Getty

Rewriting the Narrative for Youth with HIV

February 10, 2022

Aima Ahonkhai has heard the story many times: young people with HIV, feeling at a dead end. As an infectious disease clinician who works with many young people living with HIV in both the US and Nigeria, Ahonkhai, MD, MPH, has seen the toll the disease takes on young…

Infectious Diseases

Technology and Innovation

Child and Adolescent Health

Global Health NOW

illustration of dna, viruses, and vaccines

The Long History of mRNA Vaccines

October 06, 2021

A look at how this vaccine technology has been in the works for decades.

COVID-19

Technology and Innovation

Vaccines

Bloomberg School

Technology and Innovation Faculty Experts

Looking for prominent public health experts in the field of Technology and Innovation? They’re here at the Bloomberg School of Public Health.

Alain Bernard Labrique

Professor

International Health

Alain Labrique, PhD '07, MHS '99, MS, is an infectious disease epidemiologist who leverages digital innovations to solve public health problems in resource-limited settings.

Christopher D. Heaney

Associate Professor

Environmental Health and Engineering

Christopher Heaney, PhD, MS, and his team, developed a saliva-based test that accurately detects the presence of antibodies to SARS-CoV-2 from small samples of saliva.

Technology and Innovation

Technology and Innovation Headlines

AI in Public Health: Gaps, Disparities, and Remarkable Potential

Researchers Validate and Improve the Ability of Mobile Health Applications to Predict Mortality in the U.S. Population

What You Need to Know About the Novavax Protein-Based Vaccine

Study of Privately Insured Patients Finds Short-Term Telehealth Follow-Up Comparable to Most In-Person Care During First Year of COVID-19 Pandemic

Rewriting the Narrative for Youth with HIV

The Long History of mRNA Vaccines

Technology and Innovation Faculty Experts

Alain Bernard Labrique

Christopher D. Heaney

Departments

Programs

Upcoming Events